United States
|
|||
Securities and Exchange Commission
|
|||
Washington, D.C. 20549
|
|||
FORM 8-K
|
|||
Current Report Pursuant to
|
|||
Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|||
August 2, 2012
|
|||
(Date of Report)
|
|||
ULTRALIFE CORPORATION
|
|||
(Exact name of registrant as specified in its charter)
|
|||
Delaware
|
000-20852
|
16-1387013
|
|
(State of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
2000 Technology Parkway, Newark, New York
|
14513
|
||
(Address of principal executive offices)
|
(Zip Code)
|
||
(315) 332-7100
|
|||
(Registrant’s telephone number, including area code)
|
|||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
|||
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|||
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|||
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|||
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|||
Item 2.02
|
Results of Operation and Financial Condition.
|
Item 9.01
|
Financial Statements and Exhibits.
|
(d)
|
Exhibits. The following exhibit is being furnished as part of this Report.
|
Exhibit
Number |
Description
|
99.1
|
Press Release of Ultralife Corporation dated August 2, 2012
|
Date: August 2, 2012
|
ULTRALIFE CORPORATION
|
|
By:
|
/s/ Peter F. Comerford
|
|
Peter F. Comerford
|
||
Vice President of Administration and
|
||
General Counsel
|
Exhibit
Number
|
Description
|
99.1
|
Press Release of Ultralife Corporation dated August 2, 2012
|